ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $671,000 | -19.5% | 45,300 | -14.5% | 0.03% | -15.8% |
Q2 2022 | $834,000 | -41.6% | 53,000 | 0.0% | 0.04% | -28.3% |
Q1 2022 | $1,429,000 | -19.5% | 53,000 | +10.4% | 0.05% | -15.9% |
Q4 2021 | $1,776,000 | -22.5% | 48,000 | 0.0% | 0.06% | -30.0% |
Q3 2021 | $2,293,000 | +78.3% | 48,000 | +26.3% | 0.09% | +83.7% |
Q2 2021 | $1,286,000 | +3.1% | 38,000 | +25.8% | 0.05% | +14.0% |
Q1 2021 | $1,247,000 | – | 30,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |